Patient Education
Europe’s Beating Cancer Plan: The Real Failure Is Implementation
On 14 April 2026, MEP Vlad Voiculescu (Renew, Romania) presented his report on the implementation of Europe’s Beating Cancer Plan in the European...
Switching Off KRAS: A Promising Breakthrough in Pancreatic Cancer Treatment
Results from the RASolute 302 phase 3 trial show the targeted drug Daraxonrasib improves survival in metastatic pancreatic cancer after prior treat...
Landmark New England Journal of Medicine (NEJM) Publication Advances Gastric Cancer Prevention
A new New England Journal of Medicine paper, led by International Agency for Research on Cancer, outlines practical guidance for Helicobacter pylor...
When a Parent Has Cancer: How to Talk to Your Children, Honestly and Gently
Telling a child you have cancer is never easy. This practical guide helps families navigate the conversation with honesty, reassurance, and care—...
Patents, Prices, and Patients: a Global Campaign Putting Access to Medicines Under the Spotlight
New global campaign Patients and Patents highlights how pharmaceutical patent practices affect access to affordable medicines. With clear tools and...
A Turning Point Before Surgery: CASSANDRA Redefines Neoadjuvant Therapy in Pancreatic Cancer
The CASSANDRA phase III trial shows that the PAXG regimen significantly improves outcomes over mFOLFIRINOX in resectable pancreatic cancer. This pa...
Europe Approves First-line Immunotherapy for Advanced Anal Cancer
New progress for advanced anal cancer in Europe. The European Commission has approved retifanlimab with chemotherapy as a first-line treatment, hel...
BATTMAN Trial Targets Breakthrough in Hard-to-Treat Colorectal Cancer
A new Phase III trial, BATTMAN, explores combination immunotherapy for MSS metastatic colorectal cancer, a group with limited options. By targeting...
Breakthroughs, Reality Checks, and New Directions in HBP Cancer Care
The annual American Society of Clinical Oncology – Gastrointestinal (ASCO-GI) meeting highlighted a major shift in treating Hepato-Bilio-Panc...
Expanding the Biomarker Landscape on Gastric Cancer
New research presented at the 2026 ASCO GI meeting shows that understanding the biology of gastric and gastroesophageal cancers is driving more per...